Overview
- 34 inspections across 34 sites are on record.
- 81 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
34
Sites
34
Observations
81
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aqualex Co., Ltd. | 29 May 2026 | Human Drugs | On file |
| Samchundang Pharm Co., Ltd. | 19 May 2026 | Human Drugs | View 483 → |
| Bausch & Lomb Incorporated | 20 Mar 2026 | Human Drugs | On file |
| Catalent Pharma Solutions, LLC | 30 Jan 2026 | Human Drugs | On file |
| KRS PHARMACEUTICALS PRIVATE LIMITED | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Aqualex Co., Ltd.Seongnam, Korea (the Republic of)1 insp.
Samchundang Pharm Co., Ltd.Hwaseong, Korea (the Republic of)1 insp.
Bausch & Lomb IncorporatedTampa, United States1 insp.
Catalent Pharma Solutions, LLCSaint Petersburg, United States1 insp.
KRS PHARMACEUTICALS PRIVATE LIMITEDAnakapalli, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Dorothy P Kramer5 shared
Nicole E Knowlton4 shared
Jose E Melendez4 shared
Suzanne N Vallez3 shared
Javier O Vega3 shared
Angelica M Hernandez2 shared
Marian E Ramirez2 shared
Mabany Lizardi2 shared
Mickell Smith1 shared
Tammy T Brown1 shared
Full investigator report
Get the verbatim findings behind Damaris Y Hernandez's 81 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site